Finally, uromodulin, while extensively characterized as an immunomodulatory protein made exclusively by the kidney, should be characterized in preclinical animal models of sepsis and within patient populations to determine if it may have a potential therapeutic benefit as well. Here, UMOD is linked to Sepsis.